PHARMACEUTICAL DRY POWDER INHALATION FORMULATION
The present invention relates to pharmaceutical dry powder formulations, comprising (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]-amino}-5,6,7,8-tetrahydroquinoline-2-carboxylic acid of formula (I), preferably in form of one of its salt...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
06.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!